Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ADAG
ADAGENE INC.
NASDAQ
$3.68
▼ DOWN 5.64% (-0.22)

KEY STATISTICS

Market Cap$138.55 M
52w High$4.85
52w Low$1.30
Dividend Yield—
Frequency—
P/E-5.90
Volume123.15K
Shares Out.37.65M

COMPANY

LEADERSHIP

Peter Luo
CHIEF EXECUTIVE
Peter Luo

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 9, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
128

PRICE TARGET

Target High$10.00
Target Low$10.00
Target Median$10.00
Target Consensus$10.00

UPCOMING EARNINGS

DateMar 31, 2027
DayWednesday
Rev. Est.—
MAR
31
WED

PRICE

$3.68 ▼ DOWN 5.64% (−$0.22)
$3.67$3.75$3.83$3.909:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM3.68

About Adagene Inc.

https://www.adagene.com ↗

Adagene Inc. is a clinical-stage biopharma developing monoclonal antibody therapies for cancers, with multiple candidates in various clinical and preclinical stages targeting solid tumors and hematologic malignancies.

INDUSTRY

Biotechnology

A PRODUCT ADAGENE INC. IS KNOWN FOR

Muzastotug (ADG126)
Muzastotug (ADG126)

Muzastotug, Adagene’s lead masked anti-CTLA-4 SAFEbody® for solid tumors, is in Phase 1b/2 and Phase 2 trials, with FDA Fast Track for metastatic colorectal cancer, offering a targeted, safer, and more potent immunotherapy.

COMPETITORS

COMPETITOR
AGEN COMPARE
AZN COMPARE
BMY COMPARE
BNTX COMPARE
XLO COMPARE

Revenue by Products

IconPRODUCTFY2020
Service$398.88K
License$225K

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
PGJ
0.18% · 41.7K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
30.48%
HOLDERS
33
TOP 12 OF 33 · RANKED BY POSITION SIZE
Wuxi Apptec Co., Ltd.
4.0M sh · $8.84M
General Atlantic, L.P.
3.8M sh · $7.53M
Sc China Holding Ltd
1.3M sh · $2.54M
Exome Asset Management LLC
1.1M sh · $2M
Ameriprise Financial Inc
607.9K sh · $2.38M
Mill Creek Capital Advisors, LLC
199.6K sh · $782.47K
Fifth Lane Capital, LP
145.0K sh · $274.05K
Kamunting Street Capital Management, L.P.
126.0K sh · $238K
Morgan Stanley
82.8K sh · $164.68K
Citadel Advisors LLC
48.4K sh · $91.45K
Gordian Capital Singapore Pte Ltd
48.3K sh · $96.2K
Invesco Ltd.
47.1K sh · $184.73K

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book3
Overall Score2

INSIDER TRADES

★
DIRECTOR
DO CUONG V
Purchase · 2.0K shares
2026-08-14
★
DIRECTOR
Zhu Li
Purchase · 20.0K shares
2026-08-13
★
DIRECTOR
Cheung Andy Yiu Leung
Purchase · 20.0K shares
2026-08-13
★
DIRECTOR
DO CUONG V
Purchase · 20.0K shares
2026-08-13

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
Guggenheim BUY

SECTORS PEERS

PEERPRICE
FBIO$2.77COMPARE
ACET$9.06COMPARE
GANX$1.77COMPARE
OSTX$1.64COMPARE
XBIT$2.27COMPARE
NRXP$3.55COMPARE
NTRB$4.46COMPARE
TCRX$0.75COMPARE